Rocky Mountain Cancer Centers, LLP is a clinical research site located in Lakewood, Colorado, United States 80228.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Rocky Mountain Cancer Centers, LLP has participated in 7 clinical trials with 3 currently active.
Therapeutic areas: HER2-positive Breast Cancer, Colorectal Neoplasms, Ovarian Cancer.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, NuCana plc, Pfizer.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Rocky Mountain Cancer Centers, LLP has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rocky Mountain Cancer Centers, LLP has 7 clinical trials on record, with 3 currently active. Their work covers HER2-positive Breast Cancer, Colorectal Neoplasms, Ovarian Cancer.
Yes — Rocky Mountain Cancer Centers, LLP holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.